Palisade Bio Reports Third Quarter 2022 Financial Results and Provides Business Update
14.11.2022 - Carlsbad, CA, Nov. 14, 2022 (GLOBE NEWSWIRE) - Palisade Bio, Inc., (Nasdaq: PALI) a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications (the “Company” or “Palisade”), reported its ...
United States Jenene Thomas Robert Mcrae Company Annual Report On Form Exchange Commission Strategic Development Of Palisade
Source: wallstreet-online.de